Personal information

Verified email addresses

Activities

Education and qualifications (3)

Emory University: Atlanta, GA, US

2017-08 to 2022-10-12 | PhD in Cancer Biology
Education
Source: Self-asserted source
Amanda N. R. Joyce

Quinnipiac University: Hamden, CT, US

2015-08 to 2017-05 | Master of Science
Education
Source: Self-asserted source
Amanda N. R. Joyce

Quinnipiac University: Hamden, CT, US

2012-08 to 2016-05 | Bachelor of Science
Education
Source: Self-asserted source
Amanda N. R. Joyce

Works (35)

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner

JCI Insight
2023-04-24 | Journal article | Author
Part of ISSN: 2379-3708
Contributors: Brandon Ware; Maggie Phillips; Christopher McQuinn; Mohammad Y. Zaidi; Hannah Knochelmann; Emily Greene; Brian Robinson; Cameron J. Herting; Thomas A. Mace; Zhengjia Chen et al.
Source: Self-asserted source
Amanda N. R. Joyce
grade
Preferred source (of 2)‎

Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy

2023-04-04 | Preprint
Contributors: Lauren Dennison; Amanda Ruggieri; Aditya Mohan; James Leatherman; Kayla Cruz; Skylar Woolman; Nilofer Azad; Gregory B. Lesinski; Elizabeth M. Jaffee; Mark Yarchoan
Source: check_circle
Crossref

Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy

2023-04-04 | Preprint
Contributors: Lauren Dennison; Amanda Ruggieri; Aditya Mohan; James Leatherman; Kayla Cruz; Skylar Woolman; Nilofer Azad; Gregory B. Lesinski; Elizabeth M. Jaffee; Mark Yarchoan
Source: check_circle
Crossref

Supplementary Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy

2023-04-04 | Preprint
Contributors: Lauren Dennison; Amanda Ruggieri; Aditya Mohan; James Leatherman; Kayla Cruz; Skylar Woolman; Nilofer Azad; Gregory B. Lesinski; Elizabeth M. Jaffee; Mark Yarchoan
Source: check_circle
Crossref

Supplementary Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy

2023-04-04 | Preprint
Contributors: Lauren Dennison; Amanda Ruggieri; Aditya Mohan; James Leatherman; Kayla Cruz; Skylar Woolman; Nilofer Azad; Gregory B. Lesinski; Elizabeth M. Jaffee; Mark Yarchoan
Source: check_circle
Crossref

Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer

2023-04-03 | Preprint
Contributors: Yuchen Zhang; Michael B. Ware; Mohammad Y. Zaidi; Amanda N. Ruggieri; Brian M. Olson; Hannah Komar; Matthew R. Farren; Ganji Purnachandra Nagaraju; Chao Zhang; Zhengjia Chen et al.
Source: check_circle
Crossref

Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer

2023-04-03 | Preprint
Contributors: Yuchen Zhang; Michael B. Ware; Mohammad Y. Zaidi; Amanda N. Ruggieri; Brian M. Olson; Hannah Komar; Matthew R. Farren; Ganji Purnachandra Nagaraju; Chao Zhang; Zhengjia Chen et al.
Source: check_circle
Crossref

Supplementary Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer

2023-04-03 | Preprint
Contributors: Yuchen Zhang; Michael B. Ware; Mohammad Y. Zaidi; Amanda N. Ruggieri; Brian M. Olson; Hannah Komar; Matthew R. Farren; Ganji Purnachandra Nagaraju; Chao Zhang; Zhengjia Chen et al.
Source: check_circle
Crossref

Supplementary Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer

2023-04-03 | Preprint
Contributors: Yuchen Zhang; Michael B. Ware; Mohammad Y. Zaidi; Amanda N. Ruggieri; Brian M. Olson; Hannah Komar; Matthew R. Farren; Ganji Purnachandra Nagaraju; Chao Zhang; Zhengjia Chen et al.
Source: check_circle
Crossref

Data from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Data from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Figure from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Figure from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

2023-04-01 | Preprint
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

Clinical Cancer Research
2022-10-03 | Journal article
Contributors: Amanda N. Ruggieri; Mark Yarchoan; Subir Goyal; Yuan Liu; Elad Sharon; Helen X. Chen; Brian M. Olson; Chrystal M. Paulos; Bassel F. El-Rayes; Shishir K. Maithel et al.
Source: check_circle
Crossref

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

Journal of Clinical Investigation
2021-12-15 | Journal article
Contributors: Mark Yarchoan; Leslie Cope; Amanda N. Ruggieri; Robert A. Anders; Anne M. Noonan; Laura W. Goff; Lipika Goyal; Jill Lacy; Daneng Li; Anuj K. Patel et al.
Source: check_circle
Crossref

Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy

Cancer Immunology Research
2021-10-01 | Journal article
Contributors: Lauren Dennison; Amanda Ruggieri; Aditya Mohan; James Leatherman; Kayla Cruz; Skylar Woolman; Nilofer Azad; Gregory B. Lesinski; Elizabeth M. Jaffee; Mark Yarchoan
Source: check_circle
Crossref

Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor

PLOS ONE
2021-08-19 | Journal article
Part of ISSN: 1932-6203
Source: Self-asserted source
Amanda N. R. Joyce

Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer

Molecular Cancer Therapeutics
2021-01-01 | Journal article
Contributors: Yuchen Zhang; Michael B. Ware; Mohammad Y. Zaidi; Amanda N. Ruggieri; Brian M. Olson; Hannah Komar; Matthew R. Farren; Ganji Purnachandra Nagaraju; Chao Zhang; Zhengjia Chen et al.
Source: check_circle
Crossref

Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease

British Journal of Cancer
2020-10-27 | Journal article
Part of ISSN: 0007-0920
Part of ISSN: 1532-1827
Source: Self-asserted source
Amanda N. R. Joyce

Optical Control of Cytokine Signaling via Bioinspired, Polymer-Induced Latency

Biomacromolecules
2020-07-13 | Journal article
Part of ISSN: 1525-7797
Part of ISSN: 1526-4602
Source: Self-asserted source
Amanda N. R. Joyce

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

PLOS ONE
2019-10-31 | Journal article
Part of ISSN: 1932-6203
Source: Self-asserted source
Amanda N. R. Joyce